The 4-1BB costimulation augments the proliferation of CD4 +CD25+ regulatory T cells

Journal of Immunology

Volumn 173, Issue 4, 2004, Pages 2428-2434

  Zheng, Guoxing ^a   Wang, Bin ^b   Chen, Aoshuang ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COSTIMULATOR RECEPTOR 4 1BB; INTERLEUKIN 2 RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CLONAL ANERGY; CONTROLLED STUDY; EFFECTOR CELL; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE; THYMUS;

EID: 4043089873     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.4.2428     Document Type: Article

References (43)

1. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182:18.
2. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389.
3. + regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol. 14:771.
4. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:1969.
5. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431.
6. + T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163:5211.
7. + regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med. 194:823.
8. + T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J. Immunol. 169:5401.
9. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99:3493.
10. + regulatory T cells control Leishmania major persistence and immunity. Nature 420:502.
11. + T regulatory cells suppress Helicobacter hepaticus-induced colitis. J. Exp. Med. 196:505.
12. + regulatory T cells in vivo. J. Exp. Med. 198:249.
13. Klein, L., K. Khazaie, and H. von Boehmer. 2003. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100:8886.
14. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198:235.
15. Akbari, O., G. J. Freeman, E. H. Meyer, E. A. Greenfield, T. T. Chang, A. H. Sharpe, G. Berry, R. H. DeKruyff, and D. T. Umetsu. 2002. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8:1024.
16. Chen, A., G. Zheng, and M. L. Tykocinski. 2000. Hierarchical costimulator thresholds for distinct immune responses: application of a novel two-step Fc fusion protein transfer method. J. Immunol. 164:705.
17. Chen, A., G. Zheng, and M. L. Tykocinski. 2003. Quantitative interplay between activating and pro-apoptotic signals dictates T cell responses. Cell. Immunol. 221:128.
18. Zheng, G., A. Chen, R. E. Sterner, P. J. Zhang, T. Pan, N. Kiyatkin, and M. L. Tykocinski. 2001. Induction of antitumor immunity intratumoral tetracostimulator protein transfer. Cancer Res. 61:8127.
19. Tykocinski, M. L., A. Chen, J. H. Huang, M. C. Weber, and G. Zheng. 2003. New designs for cancer vaccine and artificial veto cells: an emerging palette of protein paints. Immunol. Res. 27:565.
20. + T cells. Trends Immunol. 23:378.
21. Linsley, P. S., J. L. Greene, W. Brady, J. Bajorath, J. A. Ledbetter, and R. Peach. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793.
22. + suppressor T cells in vivo. Nat. Immunol. 3:33.
23. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16:311.
24. Zuckerman, L. A., A. J. Sant, and J. Miller. 1995. Identification of a unique costimulatory activity for murine T helper 1 T cell clones. J. Immunol. 154:4503.
25. Zhou, Z., S. Kim, J. Hurtado, Z. H. Lee, K. K. Kim, K. E. Pollok, and B. S. Kwon. 1995. Characterization of human homologue of 4-1BB and its ligand. Immunol. Lett. 45:67.
26. Pollok, K. E., Y. J. Kim, J. Hurtado, Z. Zhou, K. K. Kim, and B. S. Kwon. 1994. 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells. Eur. J. Immunol. 24:367.
27. Salih, H. R., H. M. Schmetzer, C. Burke, G. C. Starling, R. Dunn, R. Pelka-Fleischer, V. Nuessler, and P. A. Kiener. 2001. Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies. J. Immunol. 167:4059.
28. Wells, A. D., H. Gudmundsdottir, and L. A. Turka. 1997. Following the fate of individual T cells throughout activation and clonal expansion: signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100:3173.
29. - T lymphocytes by 4-1BB ligand. J. Immunol. 158:551.
30. Saoulli, K., S. Y. Lee, J. L. Cannons, W. C. Yeh, A. Santana, M. D. Goldstein, N. Bangia, M. A. DeBenedette, T. W. Mak, Y. Choi, and T. H. Watts. 1998. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J. Exp. Med. 187:1849.
31. + T cells with regulatory properties from human blood. J. Exp. Med. 193:1303.
32. Lin, C. H., and T. Hunig. 2003. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur. J. Immunol. 33:626.
33. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287.
34. high regulatory cells in human peripheral blood. J. Immunol. 167:1245.
35. +high regulatory T cell function. J. Immunol. 169:6210.
36. George, T. C., J. Bilsborough, J. L. Viney, and A. M. Norment. 2003. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro. Eur. J. Immunol. 33:502.
37. Guinn, B. A., M. A. DeBenedette, T. H. Watts, and N. L. Berinstein. 1999. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine. J. Immunol. 162:5003.
38. Martinet, O., V. Ermekova, J. Q. Qiao, B. Sauter, J. Mandeli, L. Chen, and S. H. Chen. 2000. Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long-term remission of liver metastases in a mouse model. J. Natl. Cancer Inst. 92:931.
39. Melero, I., N. Bach, K. E. Hellstrom, A. Aruffo, R. S. Mittler, and L. Chen. 1998. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway. Eur. J. Immunol. 28:1116.
40. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:1295.
41. + regulatory T cells ex vivo. Blood 102:2180.
42. Takeda, I., S. Ine, N. Killeen, L. C. Ndhlovu, K. Murata, S. Satomi, K. Sugamura, and N. Ishii. 2004. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. J. Immunol. 172:3580.
43. + regulatory T cells. J. Immunol. 171:3348.